CN101041075A - Biotinylated pulullan polysaccharide nanometer grains and the preparation method - Google Patents
Biotinylated pulullan polysaccharide nanometer grains and the preparation method Download PDFInfo
- Publication number
- CN101041075A CN101041075A CN 200710057173 CN200710057173A CN101041075A CN 101041075 A CN101041075 A CN 101041075A CN 200710057173 CN200710057173 CN 200710057173 CN 200710057173 A CN200710057173 A CN 200710057173A CN 101041075 A CN101041075 A CN 101041075A
- Authority
- CN
- China
- Prior art keywords
- pulullan polysaccharide
- biotinylated
- preparation
- nanometer
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a method for preparing bioepiderm pluran-polysaccharide nanometer particles, which comprises that dissolving bioepiderm pluran-polysaccharide derivant in organic solvent, adding it into water to form suspension, then dialyzing the suspension, filtering, concentrating, freezing and drying to obtain the nanometer whose average diameter is 100-300nm. And the preparation only needs some or no surface activator, with warm reaction condition and high safety. And the preparation nanometer particle has smooth and regular surface, which can combine tumor cell, as tumor target carrier material.
Description
Technical field
The present invention relates to field of medicaments, particularly a kind of Biotinylated pulullan polysaccharide nanometer grains and preparation method thereof.
Technical background
Pulullan polysaccharide (Pullulan) Chinese also is translated into pullulan, pullulan, general poly-polysaccharide or pulullan.It is the extracellular polysaccharide of the mould generation of falx of sprouting, and with α-1, it is main that the 6-glycosidic bond constitutes the homotype polysaccharide in conjunction with maltose, be glucose by α-1, the 4-glycosidic bond is combined into maltotriose, two ends are again with α-1, the 6-glycosidic bond is with other maltotriose combination, and macromolecule polysaccharide so repeatedly is formed by connecting.α-1,4-glycosidic bond same α-1, the ratio of 6-glycosidic bond is 2: 1, the degree of polymerization (D.P) is 100-5000.Commodity pulullan mean molecule quantity 2 * 10
5, approximately form by 480 maltotrioses.This material is nontoxic, no mutagenic action, and colorless and odorless, edible, have excellent biological compatibility, can be degraded by the body endo-amylase, be a kind of excellent drug carrier material.Its aqueous solution viscosity is starkly lower than other polysaccharide solution, makes it more help practical application.Research shows that also pulullan polysaccharide can combine with the galactosylated acceptor of surface of hepatocytes, can be the medicine liver target new material is provided.But, because the water solublity of pulullan polysaccharide is extremely strong, so want in aqueous solution, to prepare can medicine carrying microgranule, must in preparation process, add cross-linking agent, as glutaraldehyde etc., these deleterious cross-linking agent are difficult to thoroughly remove at last handling process, will cause final product to have certain toxicity.In recent years, synthetic hydrophobically modified pulullan polysaccharide derivant has been widely used in the delivery system of number of chemical medicine, protein drug and genomic medicine as pharmaceutical carrier.
Biotin (biotin) claims biotin again, molecular formula C
10H
16N
2O
3S, chemical structural formula:
Biotin is a kind of water soluble vitamins of needed by human, but human body can not self be synthetic, must replenish by extraneous.Studies show that further the nearly all cell surface of human body all has biotin receptor expression, especially tumor cell.Tumor cell increases fast needs a large amount of trophic factors, and the biological example element is so cell surface meeting overexpression can form one like this and more normally organize the higher relatively zone in conjunction with biotin in conjunction with the receptor of biotin around tumor cell.Utilize these characteristics the target spot of biotin receptor as a kind of specific recognition can be had the tumor cell targeting by make material in conjunction with biotin.
Recent study shows that the pulullan polysaccharide derivant of hydrophobically modified can be self-assembled into nanoparticle by hydrophobic interaction in aqueous solution, and has been widely used in various chemicalses, the research of protein drug and genomic medicine.Nanoparticle can increase medicine in the lesions position time of staying as pharmaceutical carrier, reaches the purpose of slow release and controllable release; Method by chemical bonding is attached to nanoparticle surface to the functional groups that some have targeting or control drug release simultaneously, can realize the purpose of targeting and control sustained-release administration.The material that can be used for preparing nanoparticle must have good biocompatibility, biodegradable, and preparation method is easy.
Summary of the invention
The present invention aims to provide a kind of Biotinylated pulullan polysaccharide nanometer grains and preparation method thereof.It is the modification to the pulullan polysaccharide carrier material, characteristics in conjunction with pulullan polysaccharide and biotin, the biotinylation pulullan polysaccharide derivant of the present invention's preparation, not only be easy in water solublity, form nanoparticle, particle size distribution range is narrow, and smooth surface is regular, and have the ability of specific bond tumor cell, be a kind of tumor-targeted carrier material that better has.
The advantage of preparation method of the present invention is that nanoparticle can directly form in aqueous solution, the organic reagent of introducing can eliminate by the method for rotary evaporation or dialysis, only needs to add in the preparation process even not add any surfactant, mild condition, safety on a small quantity.
Biotinylated pulullan polysaccharide nanometer grains provided by the invention be with biotinylation pulullan polysaccharide derivant at organic solvent dissolution, add again and generate suspension in the aqueous solution, suspension is dialysed then, ultrafiltration and concentration, lyophilization gets final product.Mean diameter is the 100-300 nanometer, coefficient of dispersion 0.002-0.250.
The step of Biotinylated pulullan polysaccharide nanometer grains preparation method of the present invention is as follows:
1) at first be in organic solvent, biotin, dicyclohexylcarbodiimide and 4-dimethylamino pyridine and pulullan polysaccharide reaction, through the biotinylation pulullan polysaccharide derivant that dialysis prepares, the biotin substitution value is 20-85%.
2) biotinylation pulullan polysaccharide derivant is dissolved in (organic facies) in the organic solvent fully, stirs down and is added to (water) in the aqueous solution again, forms the nanometer suspension; Water can be water or water and ethanol, water and acetone mixed solution.Water: ethanol (volume ratio)=1: 0.5～4, water: acetone (volume ratio)=1: 0.5～4; Biotinylation pulullan polysaccharide derivant quality concentration is 0.5-10% in the organic solvent;
3) with 2) in the nanometer suspension in 1-10L water, dialysed 3-12 hour;
4) nanometer suspension ultrafiltration and concentration adds the lyophilization of 1-5% freeze drying protectant.Ultrafiltration pipe molecular cut off 30,000, revolution 1000-1800rpm, time 10-20 minute.
Organic solvent of the present invention is dimethyl sulfoxide (DMSO); Can contain surface active agent polyvinyl alcohol (PVA molecular weight 30,000-70,000) in the aqueous solution, PVA concentration: 0.1-4%; Freeze drying protectant is: mannose, sorbitol, glucose, lactose or sucrose.Organic facies: water=1: 1～20 (volume ratio).
The Biotinylated pulullan polysaccharide nanometer grains of the present invention's preparation has the ability of specific bond tumor cell, is a kind of tumor-targeted carrier material that better has.
The advantage of Biotinylated pulullan polysaccharide nanometer grains of the present invention and preparation method thereof is only to use in the preparation process mechanical agitation of low speed, nanoparticle can directly form in aqueous solution, the organic reagent of introducing can eliminate by the method for rotary evaporation or dialysis, only needs to add in the preparation process even not add any surfactant on a small quantity.Mild condition, safety.The nano-particle surface of preparation is smooth, regular.Mean diameter is the 100-300 nanometer, and particle size distribution range is narrow.
Description of drawings:
Fig. 1, Biotinylated pulullan polysaccharide nanometer grains transmission electron microscope (TEM) photo.
Fig. 2, Biotinylated pulullan polysaccharide nanometer grains particle size distribution figure.
The specific embodiment
Embodiment 1:
Get biotin 2.44g, dicyclohexylcarbodiimide (DCC) 2.06g and 4-dimethylamino pyridine (DMAP) 611mg add dissolving fully in the 50ml anhydrous dimethyl sulphoxide (DMSO), and react 1 hour.Subsequently, the 244mg pulullan polysaccharide is joined in the above-mentioned reactant liquor reaction 6 days, be reflected under the magnetic agitation and carry out.After finishing, reaction, removes the sediment D CU in the reactant liquor with reactant liquor buchner funnel sucking filtration three times.The every 25ml of filtrate is put into a bag filter, again bag filter is put into 3L deionized water dialysis 6 days, changed water once in per 30 minutes.After dialysis finishes the white depositions in the bag filter is taken out, use the buchner funnel sucking filtration 3 times, the white solid on the funnel is collected, with 200ml washed with dichloromethane 3 times, reuse deionized water wash 3 times is after the drying, obtain white solid matter, the biotin substitution value is 81%.
The substitution value assay method is as follows: accurately take by weighing product 50mg, add dissolving with hydrochloric acid and be settled to 20ml.Hydrochloric acid solution is measured the S constituent content by inductively-coupled plasma spectrometer (IPC), again according to formula:
Substitution value %=S element (molal quantity)/anhydrous grape saccharide residue (molal quantity) * 100
Calculate the biotin substitution value.
Embodiment 2:
The biotinylation pulullan polysaccharide 10mg that gets embodiment 1 preparation is dissolved among the 2mlDMSO fully, under agitation 2mlDMSO solution is joined in the 4ml deionized water, forms rapidly to have light blue opalescent nanometer suspension.Pour the nanometer suspension in the bag filter (molecular cut off 8,000-14,000), dialysis is 8 hours in the 3L deionized water.It is 30,000 ultrafiltration pipes that nanometer suspension after the dialysis is used molecular cut off, carries out ultrafiltration and concentration under 1200rpm in centrifugal 15 minutes.In ultrafiltrate, add 5% mannitol and carry out lyophilization, obtain the white powder Biotinylated pulullan polysaccharide nanometer grains.Get a certain amount of white powder and be dispersed in again in the certain volume deionized water, get scattered nanometer suspension and put into the laser particle size analyzer sample cell and carry out granularmetric analysis.Recording mean diameter is 123.6 ± 0.7 nanometers, the coefficient of dispersion 0.094.Fig. 1, Biotinylated pulullan polysaccharide nanometer grains transmission electron microscope (TEM) photo.Fig. 2, Biotinylated pulullan polysaccharide nanometer grains particle size distribution figure.
Embodiment 3:
Get biotinylation pulullan polysaccharide 10mg and be dissolved in fully among the 2mlDMSO, under the low speed magnetic agitation 2mlDMSO drips of solution is added to the aqueous phase that 5ml deionized water and 5ml ethanol mixture form, formation has light blue opalescent nanometer suspension rapidly.Pour the nanometer suspension in the bag filter (molecular cut off 8,000-14,000), dialysis is 8 hours in the 3L deionized water.It is 30,000 ultrafiltration pipes that nanometer suspension after the dialysis is used molecular cut off, carries out ultrafiltration and concentration under 1200rpm in centrifugal 15 minutes.In ultrafiltrate, add 5% mannitol and carry out lyophilization, obtain the white powder Biotinylated pulullan polysaccharide nanometer grains.Mean diameter is 170.7 ± 0.5 nanometers, the coefficient of dispersion 0.065.
Claims (9)
1, a kind of Biotinylated pulullan polysaccharide nanometer grains, it is characterized in that it is at organic solvent dissolution with biotinylation pulullan polysaccharide derivant, add again and generate suspension in the entry, suspension is dialysed then, ultrafiltration and concentration, lyophilization, mean diameter are the 100-300 nanometer, coefficient of dispersion 0.002-0.250.
2, its preparation method of the described Biotinylated pulullan polysaccharide nanometer grains of claim 1 is characterized in that the step that it comprises is as follows:
1) at first be in organic solvent, biotin, dicyclohexylcarbodiimide and 4-dimethylamino pyridine and pulullan polysaccharide reaction are through the biotinylation pulullan polysaccharide derivant of dialysing and preparing;
2) biotinylation pulullan polysaccharide derivant is dissolved in fully and forms organic facies in the organic solvent, stirs down to be added in the aqueous solution again, forms the nanometer suspension;
3) with 2) in the nanometer suspension in 1-10L water, dialysed 3-12 hour;
4) nanometer suspension ultrafiltration and concentration adds the lyophilization of 1-5% freeze drying protectant; Described ultrafiltration pipe molecular cut off 30,000, revolution 1000-1800rpm, time 10-20 minute.
3, its preparation method of Biotinylated pulullan polysaccharide nanometer grains according to claim 2 is characterized in that described aqueous solution can be water or water and ethanol, water and acetone mixed solution.
4, its preparation method of Biotinylated pulullan polysaccharide nanometer grains according to claim 3 is characterized in that: water: ethanol or acetone (volume ratio)=1: 0.5～4.
5, its preparation method of Biotinylated pulullan polysaccharide nanometer grains according to claim 3 is characterized in that: contain surface active agent polyvinyl alcohol (PVA molecular weight 30,000-70,000) in the aqueous solution, PVA concentration: 0.1-4%.
6, its preparation method of Biotinylated pulullan polysaccharide nanometer grains according to claim 2 is characterized in that biotinylation pulullan polysaccharide derivant quality concentration is 0.5-10% in the described organic solvent.
7, its preparation method of Biotinylated pulullan polysaccharide nanometer grains according to claim 2 is characterized in that described organic solvent is dimethyl sulfoxide (DMSO).
8, its preparation method of Biotinylated pulullan polysaccharide nanometer grains according to claim 2 is characterized in that described freeze drying protectant is: mannose, sorbitol, glucose, lactose or sucrose.
9, its preparation method of Biotinylated pulullan polysaccharide nanometer grains according to claim 2 is characterized in that described organic facies: water=1: 1～20, volume ratio.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710057173 CN100571781C (en) | 2007-04-20 | 2007-04-20 | Biotinylated pulullan polysaccharide nanometer grains and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710057173 CN100571781C (en) | 2007-04-20 | 2007-04-20 | Biotinylated pulullan polysaccharide nanometer grains and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101041075A true CN101041075A (en) | 2007-09-26 |
| CN100571781C CN100571781C (en) | 2009-12-23 |
Family
ID=38807005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200710057173 Expired - Fee Related CN100571781C (en) | 2007-04-20 | 2007-04-20 | Biotinylated pulullan polysaccharide nanometer grains and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100571781C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857560A (en) * | 2015-05-26 | 2015-08-26 | 西北大学 | Injectable hydrogel prepared from carboxylated pullulan and preparation method of injectable hydrogel |
| CN109984365A (en) * | 2019-05-13 | 2019-07-09 | 云南中烟工业有限责任公司 | A kind of biotinylation pulullan polysaccharide derivative is used to improve the purposes of the cigarette shreds biotin rate of transform |
| CN110692962A (en) * | 2019-10-12 | 2020-01-17 | 山东省食品发酵工业研究设计院 | Preparation method of winter jujube composite powder containing DHA algae oil nanoparticles |
| CN111494326A (en) * | 2020-04-11 | 2020-08-07 | 南京正大天晴制药有限公司 | Apixaban tablet and preparation method thereof |
| CN111557928A (en) * | 2020-05-15 | 2020-08-21 | 南通大学 | Pullulan polysaccharide nanospheres loaded with codonopside for the treatment of spinal cord injury |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2663294E (en) | 2011-01-11 | 2016-01-25 | Capsugel Belgium Nv | New hard capsules comprising pullulan |
| EP3610028A1 (en) | 2017-04-14 | 2020-02-19 | Capsugel Belgium NV | Process for making pullulan |
| WO2018189584A1 (en) | 2017-04-14 | 2018-10-18 | Capsugel Belgium Nv | Pullulan capsules |
-
2007
- 2007-04-20 CN CN 200710057173 patent/CN100571781C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104857560A (en) * | 2015-05-26 | 2015-08-26 | 西北大学 | Injectable hydrogel prepared from carboxylated pullulan and preparation method of injectable hydrogel |
| CN109984365A (en) * | 2019-05-13 | 2019-07-09 | 云南中烟工业有限责任公司 | A kind of biotinylation pulullan polysaccharide derivative is used to improve the purposes of the cigarette shreds biotin rate of transform |
| CN109984365B (en) * | 2019-05-13 | 2021-07-09 | 云南中烟工业有限责任公司 | Use of a biotinylated pullulan polysaccharide derivative for improving the biotin transfer rate of cigarette cut tobacco |
| CN110692962A (en) * | 2019-10-12 | 2020-01-17 | 山东省食品发酵工业研究设计院 | Preparation method of winter jujube composite powder containing DHA algae oil nanoparticles |
| CN111494326A (en) * | 2020-04-11 | 2020-08-07 | 南京正大天晴制药有限公司 | Apixaban tablet and preparation method thereof |
| CN111557928A (en) * | 2020-05-15 | 2020-08-21 | 南通大学 | Pullulan polysaccharide nanospheres loaded with codonopside for the treatment of spinal cord injury |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100571781C (en) | 2009-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100571781C (en) | Biotinylated pulullan polysaccharide nanometer grains and preparation method thereof | |
| Zhang et al. | Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system | |
| Namazi et al. | Hydrophobically modified starch using long-chain fatty acids for preparation of nanosized starch particles | |
| US7786095B2 (en) | Amphiphilic macrocyclic derivatives and their analogues | |
| CN108721251B (en) | Drug-carrying system for targeting β-cyclodextrin grafted chitosan ionically cross-linked nanoparticles and its preparation method and application | |
| US20060013885A1 (en) | Water soluble chitosan nanoparticle for delivering an anticancer agent and preparing method thereof | |
| CN102145173B (en) | Human serum albumin complex hydrophobically modified pullulan nanoparticles and preparation method thereof | |
| JP2002508020A (en) | Complex of polyethylene glycol and chitosan | |
| CN102139112B (en) | Drug carrier raw material and preparation method and application thereof | |
| JP2009511549A (en) | Chitosan and heparin nanoparticles | |
| WO2007086651A1 (en) | Anti-cancer agent loaded hydrophobic bile acid conjugated hydrophilic chitosan oligosaccharide nanoparticles and preparation method thereof | |
| TWI482634B (en) | Biomedical composition | |
| CN102631679A (en) | pH-sensitive pullulan ramification nano-drug carrier, drug-carrying particle and preparation of pH-sensitive pullulan ramification nano-drug carrier and drug-carrying particle | |
| CN101314622A (en) | Salicylic acid-g-chitooligosaccharide graft and its synthesis method | |
| Luzardo‐Álvarez et al. | Preparation and characterization of β‐cyclodextrin‐linked chitosan microparticles | |
| CN103205081A (en) | Preparation method for temperature-sensitive chitosan-based polyelectrolyte composite micelle | |
| Kop et al. | Polysaccharide-fullerene supramolecular hybrids: Synthesis, characterization and antioxidant activity | |
| CN101721710B (en) | Cholesteryl-carboxymethyl Curdlan nanometer particle and preparing method | |
| Enomoto-Rogers et al. | Synthesis of diblock copolymers with cellulose derivatives 4. Self-assembled nanoparticles of amphiphilic cellulose derivatives carrying a single pyrene group at the reducing-end | |
| JPH02144140A (en) | Fat emulsion stabilized with polysaccharide derivative | |
| Liang et al. | 5-Fluorouracil-loaded self-assembled pH-sensitive nanoparticles as novel drug carrier for treatment of malignant tumors | |
| US8202971B2 (en) | Process for preparing compounds of chitosan saccharified with aminosugar | |
| CN101036788A (en) | Pulullan polysaccharide carrier material having the function of targeting therapy of cancer and the preparation method | |
| CN1931370A (en) | Glycopeptide conjugate microsphere or microcapsule and its prepn process | |
| CN1698899A (en) | Novel pharmaceutical composition using chitosan or its derivatives as drug carrier |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091223 Termination date: 20100420 |